Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Alectinib 600, Non-Small Cell Lung Cancer (ALK+), Second Line

Protocol-ID: 888 V2.1 (Mini), ALEC600, NSCLC (ALK+), second line

Indication(s)

  • Lung Carcinoma, Non-Small Cell (ALK+); ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.06.2017